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This study aimed to identify which are the most frequent bacteria evolved in cases of chronic otitis in dogs in 
the metropolitan region of Curitiba, as well to determine their in vitro antimicrobial susceptibility. Data of 
positive bacterial culture from dogs affected by chronic or recurrent otitis were compiled from the records of 
the veterinary hospital of Pontifícia Universidade Católica do Paraná, Curitiba, southern Brazil. In a period 
of 16 months, a total of 83 bacterial cultures were performed, resulting in 192 isolates. All isolates were 
submitted to antimicrobial susceptibility tests, based on the Kirby-Bauer technique using 17 drugs from 8 
antibiotic classes (β-lactams, aminoglycosides, lincosamides, macrolides, polypeptides, quinolones, 
tetracyclines, and amphenicols). The five most frequent bacterial isolates were Staphylococcus spp. (58.32%), 
Proteus spp. (14.58%), Escherichia coli (9.90%) and Pseudomonas spp. (8.33%). The four most effective 
antibiotics were amikacin (13.29%), neomycin (24.47%), gentamicin (25.52%) and tobramycin (26.70%); 
however, these aminoglycosides may cause ototoxicity, and their use should be restricted when the tympanic 
membrane is intact. Quinolones also showed antimicrobial effectiveness, with 29.17% of the isolates showing 
resistance to ciprofloxacin and 29.69% to enrofloxacin. According to the results, it can be concluded that 
aminoglycosides and quinolones were effective against microorganisms of canine chronic otitis. 
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Resumo 
Este estudo teve por objetivo identificar quais as bactérias mais frequentemente envolvidas em casos de otites 
crônicas em cães da região metropolitana de Curitiba, assim como determinar sua susceptibilidade 
antimicrobiana in vitro. Dados de culturas bacterianas positivas, oriundas de cães acometidos por otite crônica 
ou recorrente foram compilados dos arquivos do hospital veterinário da Pontifícia Universidade Católica do 
Paraná, sul do Brasil. De um período total de 16 meses, foram obtidas 83 culturas bacterianas positivas, 
totalizando 192 isolados. Todas as cepas isoladas foram submetidas a provas de sensibilidade antimicrobiana 
baseadas na técnica de Kirby-Bauer, utilizando 17 drogas de 8 famílias antibióticas (β-lactâmicos, 
aminoglicosídeos, lincosaminas, macrolídeos, polipeptídeos, quinolonas, tetraciclinas e cloranfenicol). As 
cinco espécies bacterianas mais frequentes foram Staphylococcus spp. (58,32%), Proteus spp. (14,58%), 
Escherichia coli (9,90%) e Pseudomonas spp. (8,33%). Dos antibacterianos testados, os quatro que 
apresentaram menor índice de resistência foram amicacina (13,29%), neomicina (24,47%), gentamicina 
(25,52%) e tobramicina (26,70%); porém, todos eles são aminoglicosídeos e podem causar ototoxicidade, 
sendo que seu uso deve ser restringido para casos em que haja integridade da membrana timpânica. As 
quinolonas também apresentaram baixa resistência, com 29,17% dos isolados sendo resistentes à 
ciprofloxacino e 29,69% à enrofloxacino. De acordo com os dados obtidos, pode-se concluir que os 
aminoglicosídeos e as quinolonas mostraram-se mais efetivos contra as bactérias encontradas em otites 
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crônicas de cães causadas por microrganismos, principalmente em tratamentos empíricos ou em casos que não 
seja possível realizar uma cultura e antibiograma, apesar de não ser o recomendado. 




Otitis is considered a common disease of 
pets in veterinary practice. It causes great 
discomfort to animals and owners, as it can cause 
pain, itching, agitation, discharge and unpleasant 
odor. However, cases of canine otitis are often 
neglected by professionals due to a lack of accurate 
diagnosis and essential examinations such as 
bacterial culture and antibiogram of otological 
secretions (Miller et al., 2013). 
Otitis is considered a complex disease, since 
it usually involves more than one etiological 
component, complicating the diagnosis of the 
primary factors, as well as the treatment to be 
utilized (Miller et al., 2013; Griffin, 2014a; Griffin, 
2014b). 
According to Harvey et al. (2004), canine 
otitis can be classified as externa, media and 
interna, considering ear portions and anatomic 
structures that are affected. It can also be classified 
according to their laterality (unilateral or bilateral) 
and clinical evolution (acute, chronic or chronic 
recurrent). The chronic recurrent type represents up 
to 76.7% of otitis cases (Marinho et al., 2009). 
To make a correct diagnosis of otitis cases, a 
systematic and complete investigation of the 
possible causal agents is needed. The investigation 
should always include anamnesis, physical 
examination, otoscopy and sample smear for 
cytopathology of the auricular secretion 
(Matousek, 2004; Luz et al., 2014). Cytopathology 
is a fast, inexpensive and simple technique that 
offers a lot of information, being very important in 
the diagnosis, since it allows to identify yeasts, 
bacteria, keratin debris, cerumen, inflammatory 
cells and other cells (Colombini, 2005; Bensignor, 
2008; Zur, 2014).  
However, sometimes cytopathology can be 
ineffective to guide the treatment, thus whenever 
possible, it is important to perform microbial 
culture and antibiogram, particularly in chronic 
cases. These tests can lead to a more accurate 
diagnosis and better therapeutic response, since it 
allows the identification of the microbial agent and 
the most effective antimicrobial (Jacobson, 2002; 
Girão et al., 2006; Malayeri et al., 2010). 
Regarding chronic otitis, it is necessary to 
diagnose, treat or correct its primary, predisposing, 
and perpetuating etiological factors, i.e., 
identifying bacteria, yeasts, and progressive 
pathological alterations (Gotthelf, 2007; Miller et 
al., 2013; Griffin, 2014b), thereby reinforcing the 
importance of microbial culture. 
Due to the intense empirical use of 
antimicrobials, an increase in the number of drug 
associations by the pharmaceutical industry, and an 
apparent lack of antibiogram demand in the clinical 
practice are leading to an increase bacterial 
resistance in otitis cases (Zur, 2014; Cheng et al., 
2015). 
The objective of this study was to identify 
the profile of microbial agents causing chronic 
otitis in dogs diagnosed in the metropolitan region 
of Curitiba, as well as to evaluate the in vitro 
susceptibility of strains in front of different 
antimicrobials. 
 
Material and Methods 
A prospective study with clinical samples 
was carried out for the epidemiological evaluation 
of the bacteria isolated from the chronic or 
recurrent otitis in dogs, during a period of 16 
months. The animals were diagnosed and treated at 
the Veterinary Hospital of the Pontifícia 
Universidade Católica do Paraná (PUCPR).  
Adult dogs diagnosed with chronic or 
recurrent and unilateral or bilateral otitis, were 
selected regardless of breed and gender. Based on 
the presence of erythema on the concave portion of 
the auricular pinna and auditory canals, excessive 
production of cerumen and/or the presence of pus, 
auricular pruritus and/or headaches over a period of 
more than 30 days or intermittent episodes; as well 
as animals with signs of chronicity, such as 
epithelial hyperplasia, excess skin folds, fibrosis, 
calcification and stenosis of the ducts that 
presented a positive cytological diagnosis for the 
presence of bacteria and a positive bacterial 
culture. 
Animals with acute otitis (less than 30 days 
of evolution), with no detectable microorganisms 
from bacterioscopy nor microbial growth on 
bacterial cultures, were excluded from the study. 
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All the animals underwent complete 
evaluation consisting of anamnesis, emphasizing 
the data on the clinical and epidemiological aspects 
of otitis in order to determine the time of evolution 
of the clinical picture. A direct inspection was 
performed on both ears to detect any signs of 
chronic otitis: epithelial hyperplasia, presence of 
skin folds, fibrosis and stenosis of ducts. In 
addition, all animals went through otoscopic 
examination in which the otoscope was introduced 
into the vertical conduit and, when possible, in the 
horizontal conduit to determine the presence or 
absence of edema, erythema, exudation, foreign 
body, neoplastic nodules or tumors, stenosis and 
the integrity and aspects of the tympanic 




In cases where the presence of any type of 
secretion or exudate was evident, a sample of the 
otological secretion of the affected ear(s) was 
collected with the aid of a non-sterile swab for 
cytopathology; the smear was performed by 
spreading the sample on the glass slide by rotating 
the swab on the surface and then allowing it to dry 
for 5-10 minutes at room temperature until the 
surface of the secretion was completely dry. After 
drying, the slides were stained with rapid panoptic 
staining (Instant Prov®)1. 
The sample was observed under a 
microscope at 1000x magnification (immersion 
objective) to visualize the possible bacteria. It was 
possible to diagnose if the otitis was of bacterial 
origin or not, and, in cases of bacterial otitis, to 
determine if they were aggravated by the growth of 
bacteria of cocci or bacilli shapes. 
Once the presence of bacteria was observed 
in cytopathology, a new sample of auricular 
secretion was collected in sterile form; for this a 
sterile swab was placed in the vertical portion of 
the auricular canal or, when possible, in the 
horizontal portion. This swab was wrapped in a 
plastic tube with Stuart's medium inside and later 
sent for bacterial culture and antibiogram at the 
microbiology laboratory of the Veterinary Hospital 
of PUCPR. In cases of bilateral bacterial otitis, this 
procedure was repeated in the contralateral 
conduit. 
 
Culture and bacterial identification 
All the positive cytopathology samples, or in 
bilateral otitis, samples of both ears were 
inoculated in 5% sheep blood agar Petri-dish and in 
MacConkey agar Petri-dish. and incubated at 37°C 
for 24-48 hours. Observations were made every 24 
hours of incubation. Cultures that could not grow 
in a maximum period of 48 hours were considered 
negative. 
In positive cases, the identification would be 
based on colony morphology, Gram staining 
characteristics, enzymatic tests, biochemical 
profile (Quinn et al., 2011) characterized by a 
commercial kit for enterobacteria (NewProv, 
Produtos para Laboratórios, Pinhais, Brasil) and for 
non-fermenting bacteria (NewProv, Produtos para 
Laboratórios, Pinhais, Brasil) to determine Gram-
negative genera. 
Figure 1 shows the schematic of the protocol 








Based on the technique described by Kirby 
and Bauer (Bauer et al., 1966), antimicrobial 
susceptibility tests were performed on each isolate 
using the following drugs: cefalexin, cefovecin, 
amoxicillin + clavulanic acid, ampicillin, penicillin 
G, amicacine, streptomycin, gentamicin, 
neomycin, tobramycin, lincomycin, erythromycin, 
polymyxin B, ciprofloxacin, enrofloxacin, 
doxycycline and chloramphenicol. 
In total, 17 antibiotics divided into eight 
groups were tested, as shown in Table 1. 
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Table 1.  Groups, classes and antibiotics used for antimicrobial susceptibility testing. 
Groups Classes Antibiotics 
01 β-Lactams Amoxicillin with clavulanic acid (AMC), ampicillin (AMP), cephalexin 
(CPX), cefovecin (CFN), and penicillin G (PEN) 
02 Aminoglycosides Amicacin (AMI), streptomycin (STR), gentamicin (GEN), neomycin 
(NEO), and tobramycin (TOB) 
03 Lincosamides Lincomycin (LIN) 
04 Macrolides Erythromycin (ERY); 
05 Polypeptides Polymyxin B (POL); 
06 Quinolones Ciprofloxacin (CIP) and enrofloxacin (ENO) 
07 Tetracyclines Doxycycline (DOX) 
08 Amphenicols Chloramphenicol (CLO) 
 
Statistical analysis 
For statistical analysis of epidemiological 
data and in vitro susceptibility to antimicrobials, 
Fischer's exact test or the Chi-square test were used 
to evaluate the association between qualitative 
variables. All data were described in percentage 
and statistical software GraphPad Prism, version 
5.00 for Macintosh®, San Diego – California, USA 
was used. The level of significance was set at 5% 
(p<0.05) (Petrie and Watson, 2009). 
 
Results 
The study included 70 animals, 40 females 
(57.14%) and 30 males (42.86%), and no 
difference (p=0.4980) was found for gender. 
Of all the animals evaluated, 25.71% (18) 
were crossbred animals; 15.71% (11) were Lhasa 
Apso; 10% (7) Poodle; 5.71% (4) Cocker; 5.71% 
(4) Labrador Retriever; 5.71% (4) Pit Bull; 5.71% 
(4) Shar-pei; 4.29% (3) Yorkshire Terrier; 2.86% 
(2) Maltese Bichon; 2.86% (2) Pinscher; 2.86% (2) 
Pug; 2.86% (2) Rottweiler; 1.43% (1) Boxer; 
1.43% (1) Dachshund; 1.43% (1) Golden 
Retriever; 1.43% (1) German Shepherd; 1.43% (1) 
Swiss Shepherd; 1.43% (1) Shi Tzu and 1.43% (1) 
West Highland White Terrier. 
 
Microbiology of otological secretion of dogs with 
chronic otitis 
Of the 70 animals evaluated, 11.46% (8) had 
to repeat the culture at least once because of 
recurrences, so a total of 83 cultures with bacterial 
growth were obtained. 
In relation to laterality, 65.10% (54) of the 
cultures came from bilateral otitis and 34.90% (29) 
from unilateral otitis. Among unilateral otitis, 
62.06% (18/29) were from the right ear and 37.94% 
(11/29) from the left ear; a total of 137 ear cultures 
were performed without significant difference 
between the affected sides (p=0.7179). 
A total of 192 bacterial isolates were 
obtained from the 137 ears cultures; 53.64% 
(103/192) were from the right ear and 46.35% 
(89/192) were from the left ear, but without 
significant difference (p=0.5401). 
Regarding bacterial identification (Figure 2), 
the 192 isolates were classified as 58.32% (112) 
Staphylococcus spp., 14.58% (28) Proteus spp., 
9.90% (19) Escherichia coli, 8.33% (16) 
Pseudomonas spp. and reported with less 
frequency 2.08% (4) Bacillus spp., 2.08% (4) 
Streptococcus spp., 1.56% (3) Corynebacterium 
spp., 1.56% (3) Serratia spp., 0.52% (1) 
Acinetobacter spp., 0.52% (1) Enterobacter spp. 
and 0.52% (1) Morganella spp. 
In vitro antimicrobial susceptibility tests 
were performed for all isolates using previously 
mentioned drugs: cefalexin (CFX; 192), cefovecin 
(CVN; 72), amoxicillin with clavulanic acid 
(AMC; 189), ampicillin (AMP; 192), penicillin G 
(PEN; 191), amicacin (AMI; 158), streptomycin 
(STR; 181), gentamicin (GEN; 192), neomycin 
(NEO; 192), tobramycin (TOB; 191), lincomycin 
(LIN; 136), erythromycin (ERY; 192), polymyxin 
B (POL; 192), ciprofloxacin (CIP; 192), 
enrofloxacin (ENO; 192), doxycycline (DOX; 184) 
and chloramphenicol (CLO; 186). 
Regarding the in vitro bacterial 
susceptibility to β-lactams, 35.94% (69/192) were 
resistant to CFX; 48.61% (35/72) to CVN; 31.75% 
(60/189) to AMC; 65.96% (124/192) to AMP and 
76.44% (146/191) presented resistance to PEN. 
In the aminoglycoside class, 13.29% 
(21/158) were resistant to AMI; 44.20% (80/181) 
to STR; 25.52% (49/192) to GEN; 24.48% 
(47/192) to NEO and 26.70% (51/191) were 
resistant to TOB. 
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Figure 2. Distribution of different bacterial species 
isolated from chronic otitis in dogs from the 
Veterinary Hospital of Pontifícia 
Universidade Católica do Paraná 
(PUCPR). 
 
In the lincosamine class, 67.65% (92/136) 
were resistant to LIN; in the macrolide class, there 
was a resistance to ERY in 65.63% (126/192) of 
the cases; in the polypeptide class, 34.90% 
(67/192) showed resistance to POL. 
Within the quinolone class, CIP presented 
resistance in 29.17% (56/192) of the samples and 
29.69% (57/192) of the samples were resistant to 
ENO. 
In relation to the tetracycline class, 45.65% 
(84/184) of the bacterial cultures were resistant to 
DOX; and for the amphenicol class, 31.72% 
(59/186) were resistant to CLO. 
  
Antimicrobial multiresistance 
In this study the antibacterial classes tested 
were β-lactams, aminoglycosides, lincosamines, 
macrolides, polypeptides, quinolones, tetracyclines 
and amphenicols; of the 192 isolates, 109 (56.77%) 
proved to be multiresistant. 
Table 2 shows the relationship between the 
isolates and their resistance to at least three classes 
of antimicrobials tested. 
 
Discussion 
The present study did not demonstrate 
gender predisposition for chronic otitis. This 
indicates that sexual hormones have no influence 
over otitis occurrence. However, anatomic factors 
such as excess hair in the ducts, pendular ears, a 
natural stenosis of auditory conducts, may be 
predisposing factors for this (Cole, 2009; Cole, 
2012). 
The breeds that presented most with otitis in 
this study were Lhasa Apso, Poodle, Cocker, 
Labrador Retriever, Pit Bull and Shar-pei. In 
addition, Lhasa Apso and Poodle are frequently 
affected by atopic dermatitis, and Cocker and 
Labrador present primary keratinization disorders 
or are seboatopics, these morbidities are often 
involved as the primary cause of otitis (Cole, 
2012). 
In total, the genus Staphylococcus accounted 
for almost 60% of the strains isolated in this study. 
A possible explanation for this prevalence may be 
the fact that they are part of the indigenous 
microbiota of the healthy ear ducts (Cole, 2009), 
and its overgrowth occurs due to the physical-
chemical changes of the ear canal and auditory 
canal epithelia, as well as alterations in the 
production of cerumen associated with the primary 
etiological factors of otitis in dogs (Angus, 2005; 
Cole, 2009). 
Staphylococcus spp. was the main secondary 
agent of chronic otitis in dogs in the present study. 
Increased staphylococcal adhesion, colonization 
and overgrowth have been commonly observed in 
dogs with atopic dermatitis and primary seborrhea, 
suggesting that the same process occurs in the 
auditory ducts of these dogs and favors 
staphylococcal infections of a secondary nature 
(Oliveira et al., 2008). 
Additional studies, however, are required to 
know whether colonization and auricular 
staphylococcal infection of these animals may be a 
source of infection to the skin, and may favor 
repeat infections in dogs with atopic dermatitis or 
with primary keratinization disorders (Oliveira et 
al., 2008). 
 
Table 2. Relationship between different bacterial 
species and their multiresistance to at least three classes 






Staphylococcus spp. 112 55 (49.11%) 
Proteus spp. 28 27 (96.43%) 
Pseudomonas spp. 16 12 (75.00%) 
Escherichia coli 19 9 (47.37%) 
Serratia spp. 3 3 (100.00%) 
Acinetobacter spp. 1 1 (100.00%) 
Bacillus spp. 4 1 (25.00%) 
Morganella spp. 1 1 (100.00%) 
 
Among Gram-negative bacteria isolated 
from chronic or recurrent otitis of the present study, 
Proteus mirabilis and Escherichia coli prevailed. 
Both are enterobacteria, and Escherichia coli is a 
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bacterium specific to the intestines of dogs and 
other animals, including humans (Quinn et al., 
2011), suggesting that the source of infection by 
these bacteria could be fecal and colonization from 
contact with the contaminated environment, water 
or after pruritus (Cheng et al., 2015). Another 
hypothesis for the origin of these bacteria is that 
these microorganisms colonize the ear canals of 
healthy dogs and, as with Staphylococcus species, 
infection would be the result of microbial 
overgrowth after otitis was established (Cole, 
2009; Cole, 2012). 
Pseudomonas spp. were isolated in chronic 
otitis in the present study less frequently than in 
previous studies (Hariharan et al., 2006; Penna et 
al., 2011; Bugden, 2013). These microorganisms 
originate from the environment, such as soil, water, 
plants; or the skin, mucous membranes and feces 
(Quinn et al., 2011). This lower occurrence may be 
explained by the fact that chronic otitis and 
recurrent chronic otitis in dogs are frequently 
related to allergic dermatopathies 
(Saridomichelakis et al., 2007), and in these 
animals the colonization of the skin by bacteria of 
the genus Staphylococcus is more frequent, which 
prevents the growth of other bacterial species 
(Oliveira et al., 2008). 
Topical therapy is essential for the treatment 
of external otitis, since systemic therapy is 
ineffective and antibiotics administered orally or 
parenterally do not reach therapeutic 
concentrations in the fluids or exudates of the 
auditory ducts unless the epithelium is eroded or 
ulcerated in a wide region (Morris, 2004). 
In the cases of otitis media, systemic therapy 
is necessary because the tympanic bulla is covered 
by a highly vascularized epithelium, which allows 
the medications used systemically to achieve 
adequate levels of antibiotic concentration (Morris, 
2004). 
In the present study, aminoglycosides 
(amicacin, neomycin, gentamicin and tobramycin), 
and quinolones (ciprofloxacin and enrofloxacin) 
were shown to be effective against more than 70% 
of the isolated microorganisms. This good response 
of aminoglycosides may be related to their wide 
spectrum of activity, mainly against Gram-negative 
bacteria (Penna et al., 2009; Magiorakos et al., 
2012). The high sensitivity found for amicacin may 
be due to the fact that it does not have a commercial 
presentation available in the veterinary 
pharmacopoeia, and with that, it is rarely used 
(Magiorakos et al., 2012). 
The good efficiency of neomycin, 
gentamicin and tobramycin, although frequently 
prescribed by veterinarians, can be explained by 
the fact that Staphylococcus spp. was the bacterial 
genus found in most of the chronic otitis in the 
present study. This genus can develop a mechanism 
of resistance related to mecA gene, with production 
of strains resistant against beta-lactam, but 
maintaining sensitivity to aminoglycosides 
(Griffin, 2014b). 
Despite the high sensitivity to 
aminoglycosides, this class of antibiotics should be 
used with caution due to its ototoxic effects when 
administered topically in animals with ruptured 
tympanic membrane (Wooltorton, 2002), and 
because they are nephrotoxic (in addition to 
ototoxic) when used in a systemic way (Rang et al., 
2010; Giguère et al., 2013). 
Ciprofloxacin and enrofloxacin are broad-
spectrum antibiotics having bactericidal effects on 
both Gram-negative bacteria and Gram-positive 
bacteria. These are safe, even in cases of tympanic 
membrane rupture, since they are not ototoxic 
(Daniel and Munguia, 2008; Lemke et al., 2009), 
and may also be indicated for systemic use in cases 
of otitis media (Griffin, 2014b). 
In the present study, other drugs that 
demonstrated good in vitro efficacy for topical use 
were chloramphenicol and polymyxin B. 
Chloramphenicol has limited use because its 
administration is associated with reversible and 
non-regenerative anemia in dogs and in humans, 
damage in the DNA of hematopoietic stem cells 
and irreversible medullary aplasia (Moraes and 
Takahira, 2010). The polymyxin B is a cheap 
molecule, widely used in medicine, but its 
ototoxicity limits its use exclusively to cases where 
there is integrity of the tympanic membrane 
(Morris, 2004). 
Antibiotics that showed a sensitivity of less 
than 60% were streptomycin, doxycycline, 
cefovecin, erythromycin, ampicillin, lincomycin 
and penicillin, which contraindicates their 
prescription and empirical use in dogs with chronic 
otitis. 
Some variability in antibiotic resistance can 
occur due to geographical differences between 
studies (Bugden, 2013). This can justify the 
difference in the findings of the present study 
compared to results obtained by Oliveira et al. 
(2005) and Penna et al. (2009), that worked in the 
northeast and southeast of Brazil, noticeably 
warmer than the southern region of Curitiba, which 
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is located in the south of Brazil. Another possible 
justification is the inclusion criteria, since in the 
present study only cases of chronic and recurrent 
otitis, which usually have resistant or multiresistant 
secondary infections, were selected. 
It is worth noting that all information 
obtained from culture and antimicrobial sensitivity 
tests, based on the disc diffusion method described 
by Bauer et al. (1966), refer to serum 
concentrations. However, the concentrations 
obtained in the topical therapies are higher than 
those obtained in plasma, which justifies that some 
bacteria considered resistant in in vitro tests are 
susceptible to the active principles when used in 
otological products in vivo (Morris, 2004). 
Thus, bacteria considered partially sensitive 
to a given antibiotic can be considered sensitive 
when it is used topically and resistant to this drug 
in systemic therapies (Griffin, 2014b; Cheng et al., 
2015). 
The antibiotic that was most likely to be 
effective in the treatment of otitis was amicacin, 
but its use should be reserved for cases that do not 
respond to other treatments, thus reducing the risk 
of the onset of resistance (Moraes and Takahira, 
2010). 
In the present study, since only dogs with 
persistent chronic or chronic intermittent otitis 
were evaluated, there was a high incidence of 
bacterial multiresistance, which may be related to 
the widespread and indiscriminate use of 
antibiotics (Bugden, 2013). 
The mechanisms of antibiotic resistance 
have been associated with the presence of specific 
resistance genes in plasmids, and the bacteria have 
the capacity to transmit this genetic material to 
others of the same genus and species, as well as to 
other phylogenetically distant bacteria, conferring 
antibiotic protection (Giguère et al., 2013). 
Proteus spp. showed multiresistance in 
almost all isolates. It is unknown why this 
bacterium is capable of inducing multiresistance 
and creating mechanisms of antimicrobial 
protection, but 16 antimicrobial resistance genes 
have been described in bacteria of this genus. This 
gives them resistance to β-lactams, 
fluoroquinolones, streptomycin, tetracyclines, 
trimethoprim sulfate (Cheng et al., 2015). 
In the case of Pseudomonas spp., cross-
resistance to antimicrobials and biofilm formation 
makes it difficult to contact the bacterium with the 
antibiotic and facilitates the creation of new 
resistance mechanisms through prolonged 
exposure at low doses (Pye et al., 2013). 
Another bacterium that presented a high 
index of multiresistance was Staphylococcus spp. 
A feasible explanation for this high prevalence is 
that this genus may originate from humans, which 
receive antibiotic therapy more frequently, which 
increases the risk of resistance mechanisms on 
exposed bacteria (Huang et al., 2009). The 
resistance to β-lactam drugs in the genus 
Staphylococcus may be due to the presence of the 
mecA gene, which can be transmitted between the 
different coagulase-positive (Staphylococcus 
pseudintermedius and Staphylococcus aureus) and 
coagulase-negative (Staphylococcus equorum, 
Staphylococcus felis and Staphylococcus 
gallinarum) bacteria (Giguère et al., 2013). 
In addition, biofilm formation has recently 
been described in strains of the genus 
Staphylococcus isolated from dogs with otitis 
(Moreira et al., 2012), which, as explained in the 
case of Pseudomonas spp., decreases the amount of 
antibiotic to which they are exposed, facilitating 
generation of resistance (Pye et al., 2013). 
 
Conclusion 
It is concluded that Staphylococcus spp. and 
Proteus spp. are the main bacteria isolated from 
chronic and recurrent otitis in dogs; the most 
effective antibiotics for the treatment of external 
otitis are amicacin, neomycin, gentamicin and 
tobramycin, of the class of aminoglycosides and 
ciprofloxacin and enrofloxacin, of the quinolone 
class, respectively. 
Gram-positive and Gram-negative strains of 
multiresistant bacteria for antimicrobials are 
commonly isolated in dogs with chronic otitis. 
Due to this large multiresistance present in 
bacteria isolated in cases of chronic otitis, the use 
of empirical therapies is not recommended because 
of the high risk of an insufficient treatment 
response, as well as the possibility of creating new 
resistance. 
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